Article
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trial.
PloS one - 1 Jan 2014
Pavelitz Thomas, Renfro Lindsay, Foster Nathan R, Caracol Amber, Welsch Piri, Lao Victoria Valinluck, Grady William B, Niedzwiecki Donna, Saltz Leonard B, Bertagnolli Monica M, Goldberg Richard M, Rabinovitch Peter S, Emond Mary, Monnat Raymond J, Maizels Nancy
Abstract excerpt
PURPOSE: Colon cancers deficient in mismatch repair (MMR) may exhibit diminished expression of the DNA repair gene, MRE11, as a consequence of contraction of a T11 mononucleotide tract. This study investigated MRE11 status and its association with prognosis, survival and drug response in patients with stage III colon cancer. PATIENTS AND METHODS: Cancer and Leukemia Group B 89803 (Alliance) randomly assigned...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
